Study details
Enrolling now
Recovery From DEXmedetomidine-induced Unconsciousness
Massachusetts General Hospital
NCT IDNCT06003127ClinicalTrials.gov data as of Apr 2026
Target enrollment
12
Study length
about 1.3 years
Ages
18–65
Locations
1 site in MA
About this study
This trial is testing if biological sex affects recovery from dexmedetomidine sedation, and if a device can measure brain complexity during sedation without waking participants. The treatment involves transcranial magnetic stimulation combined with electroencephalography.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Transcranial Magnetic Stimulation-Electroencephalography
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low14%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Devices
therapeutic